On December 2, 2024, Johanna Roberts, Executive Vice President, General Counsel & Secretary at Penumbra Inc, sold 600 shares of the company. Following this transaction, the insider now owns 63,444 shares of Penumbra Inc.
Penumbra Inc (PEN, Financial) is a global healthcare company focused on innovative therapies. The company designs, develops, manufactures, and markets medical devices for use by healthcare professionals to treat patients suffering from various medical conditions.
The insider transaction history for Penumbra Inc indicates that there have been no insider buys over the past year, while there have been 26 insider sells during the same period. Over the past year, Johanna Roberts has sold a total of 6,000 shares and has not purchased any shares.
On the day of the recent sale, shares of Penumbra Inc were trading at $244.49, giving the stock a market cap of $9.412 billion. The company's price-earnings ratio stands at 285.16, which is higher than the industry median of 29.95 but lower than the company’s historical median price-earnings ratio.
With a trading price of $244.49 and a GuruFocus Value of $279.33, Penumbra Inc has a price-to-GF-Value ratio of 0.88, indicating that the stock is modestly undervalued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on three factors:
- Historical multiples (price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow) that the stock has traded at.
- A GuruFocus adjustment factor based on the company’s past returns and growth.
- Future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
